Arros AI

Arros is a precision oncology company that utilizes artificial intelligence and machine learning to accelerate the discovery of novel small molecule drugs. The company focuses on targeting specific genetic drivers of cancer that have historically been difficult to address with traditional drug discovery methods. By combining computational chemistry with structural biology and deep oncology expertise, Arros aims to develop highly selective therapies for patients with unmet medical needs. The firm was founded by a team of experienced drug hunters with a track record of success in the biotechnology industry, including former leaders from Loxo Oncology. Arros is currently advancing a pipeline of programs focused on high-value, genetically defined oncology targets.